Follow on Google News Industry News News By Place Country(s) Industry News
Follow on Google News | Laura DeForge, Sr Scientist at Genentech to speak at 5th Assay Conference Sept 20-21, 2010 San DiegoThis conference will also provide a venue for professionals in the drug discovery industry and academics to get an update of exciting new developments in assay technologies and exchange ideas in developing creative approaches in the drug discovery
By: GTCbio Laura DeForge will give a presentation on “Real-time Impedance-based Bioassays Using the xCELLigence™ Laura DeForge received her Ph.D. in Pharmacology from the University of Michigan and did her post-doctoral training in cytokine biology in the Department of Pathology, also at the University of Michigan. After working on novel approaches to inhibiting cytokine production at a start-up company, Laura joined Genentech in 1994, first in the Development organization, and then moved to the Assay & Automation Technology (AAT) Department in Research in 1997. She currently leads her group to develop a broad range of assay types, including quantitative immunoassays, anti-therapeutic antibody assays, immunochemical and cell-based binding assays, activity indicating cell-based and enzymatic potency assays, and multiplexed assays using various technologies. Most of her work currently focuses on antibody therapeutics for immunology indications. Also presenting at the Assay and Drug Discovery Technologies are prestigious organizations including Burnham Medical Research Institute, Pfizer, UCSF, AstraZeneca, UCLA, Bristol Myers Squibb, Genentech, National Institute of Advanced Science and Technology, Johnson & Johnson, Nexigen GmbH, University of Pennsylvania, Roche, UCD, Abbott, Merck, Novartis (GNF), and other leaders in the Assay and Drug Discovery Technologies industry. 5th Assay and Drug Discovery Technologies Conference features a mixture of academic, industry and public sector experts in an intimate setting that favors the showcase of data, the exchanges of ideas and networking. Professionals in the drug discovery industry and academics to can get an update of exciting new developments in assay technologies and exchange ideas in developing creative approaches in the drug discovery and development process to improve the efficiency and output. For more information, visit www.gtcbio.com. End
Account Email Address Disclaimer Report Abuse
|
|